{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:21Z","timestamp":1792784301149,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["K2010-63P-21562-01-4"],"award-info":[{"award-number":["K2010-63P-21562-01-4"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["K2011-61X-20401-05-6"],"award-info":[{"award-number":["K2011-61X-20401-05-6"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JPND project BIOMARKAPD"},{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.parkreldis.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T18:25:15Z","timestamp":1390415115000},"page":"382-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["CSF \u03b1-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-3614","authenticated-orcid":false,"given":"Stefania","family":"Mondello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jeromin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2014.01.011_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.parkreldis.2014.01.011_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S1353-8020(11)70006-2","article-title":"Vaccination for Parkinson's disease","volume":"18","author":"Schneeberger","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/35086067","article-title":"Failure of the ubiquitin-proteasome system in Parkinson's disease","volume":"2","author":"McNaught","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.53.8.1858","article-title":"Case\u2013control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease","volume":"53","author":"Maraganore","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1468-1331.2007.02012.x","article-title":"Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease","volume":"15","author":"Hutter","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/hmg\/ddg211","article-title":"Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron","volume":"12","author":"Osaka","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/mds.20575","article-title":"UCHL-1 gene in multiple system atrophy: a haplotype tagging approach","volume":"20","author":"Healy","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2005.11.005","article-title":"Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies","volume":"22","author":"Barrachina","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib11","first-page":"189","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"74","author":"Gilman","year":"1998","journal-title":"J\u00a0Autonomic Nervous Syst"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele\u2013Richardson\u2013Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1227\/NEU.0b013e318236a809","article-title":"Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury","volume":"70","author":"Mondello","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib15","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e3182904d43","article-title":"alpha-Synuclein in CSF of patients with severe traumatic brain injury","volume":"80","author":"Mondello","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib20","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/cc10286","article-title":"Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study","volume":"15","author":"Mondello","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib21","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2119\/molmed.2011.00259","article-title":"Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients","volume":"17","author":"Ehrenreich","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4161\/auto.5604","article-title":"Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease","volume":"4","author":"Engelender","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib23","series-title":"Atypical parkinsonian disorders","article-title":"Neuropathology of atypical parkinsonian disorders","author":"Mackenzie","year":"2005"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20017","article-title":"UCHL1 is a Parkinson's disease susceptibility gene","volume":"55","author":"Maraganore","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib25","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.0806474106","article-title":"Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease","volume":"106","author":"Liu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib26","series-title":"Protein misfolding diseases: current and emerging principles and therapies","first-page":"817","article-title":"Identifying targets in alpha-synuclein metabolism to treat Parkinson's and related disorders","author":"Tomlinson","year":"2010"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/7.5.913","article-title":"Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions","volume":"7","author":"Holmberg","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib29","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.23670","article-title":"Cerebrospinal fluid Tau\/alpha-synuclein ratio in Parkinson's disease and degenerative dementias","volume":"26","author":"Parnetti","year":"2011","journal-title":"Mov Disord"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.parkreldis.2014.01.011_bib30","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/ana.10570","article-title":"Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia","volume":"54","author":"Boeve","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.01.011_bib32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain: J Neurol"},{"issue":"Suppl.\u00a012","key":"10.1016\/j.parkreldis.2014.01.011_bib33","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/mds.20536","article-title":"Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting","volume":"20","author":"Scaravilli","year":"2005","journal-title":"Mov Disord: Off J Mov Disord Soc"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014000133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014000133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T05:01:02Z","timestamp":1648098062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802014000133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1353802014000133"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.01.011","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF \u03b1-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}